Chunghai Pharm has 4 approved products in 2023, including Hemlibra, and has treated 20,000 patients
Register to read the full analysis —or— Upgrade to access more features
#Research and Development
#disease
#cure
#medicine
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.